Adjuvant β-defensins, a TLR3 agonist, acts as a strong immunostimulant that provokes an immune response by binding to its corresponding receptors, TLRs and CCR6, activating both immature dendritic cells and naïve T-cells at the infection location [40]. Here, CCR6 is linked to infection.